431 related articles for article (PubMed ID: 16197646)
1. [Predictors of cardiovascular mortality and morbidity in hypertension].
Laurent S
Curr Med Res Opin; 2005; 21 Suppl 5():S7-11. PubMed ID: 16197646
[TBL] [Abstract][Full Text] [Related]
2. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms.
Nichols WW
Am J Hypertens; 2005 Jan; 18(1 Pt 2):3S-10S. PubMed ID: 15683725
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination.
Asmar RG; London GM; O'Rourke ME; Mallion JM; Romero R; Rahn KH; Trimarco B; Fitzgerald D; Hedner T; Duprez D; De Leeuw PW; Sever P; Battegay E; Hitzenberger G; de Luca N; Polónia P; Bénétos A; Chastang C; Ollivier JP; Safar ME;
J Hypertens Suppl; 2001 Nov; 19(4):S15-20. PubMed ID: 11848258
[TBL] [Abstract][Full Text] [Related]
4. [Drugs and arterial stiffness in hypertensive patients].
Laurent S
Drugs; 2003; 63 Spec No 1():1-8. PubMed ID: 12708878
[TBL] [Abstract][Full Text] [Related]
5. Large-artery stiffness, hypertension and cardiovascular risk in older patients.
Blacher J; Safar ME
Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):450-5. PubMed ID: 16265585
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME
J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203
[TBL] [Abstract][Full Text] [Related]
7. [New goals in hypertension management: target-organ protection beyond blood pressure lowering].
Safar ME; Struijker-Boudier HA
Drugs; 2003; 63 Spec No 1():45-7. PubMed ID: 12708882
[TBL] [Abstract][Full Text] [Related]
8. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
Gosse P
Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
[TBL] [Abstract][Full Text] [Related]
9. Brachial arterial pressure to assess cardiovascular structural damage: an overview and lessons from clinical trials.
London GM
J Nephrol; 2008; 21(1):23-31. PubMed ID: 18264933
[TBL] [Abstract][Full Text] [Related]
10. Pulse pressure reduction and cardiovascular protection.
Laurent S; Tropeano AI; Boutouyrie P
J Hypertens Suppl; 2006 May; 24(3):S13-8. PubMed ID: 16723861
[TBL] [Abstract][Full Text] [Related]
11. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
Epstein BJ; Anderson S
Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
[TBL] [Abstract][Full Text] [Related]
12. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
Pede S; Lombardo M
Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive treatment alters the predictive strength of pulse pressure and other blood pressure measures.
Greenberg J
Am J Hypertens; 2005 Aug; 18(8):1033-9. PubMed ID: 16109316
[TBL] [Abstract][Full Text] [Related]
14. Arterial stiffness and central hemodynamics in treated hypertensive subjects according to brachial blood pressure classification.
Safar ME; Blacher J; Protogerou A; Achimastos A
J Hypertens; 2008 Jan; 26(1):130-7. PubMed ID: 18090550
[TBL] [Abstract][Full Text] [Related]
15. Is systolic pressure a better target for antihypertensive treatment than diastolic pressure?
Leonetti G; Cuspidi C; Facchini M; Stramba-Badiale M
J Hypertens Suppl; 2000 Jul; 18(3):S13-20. PubMed ID: 10952083
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk as defined in the 2003 European blood pressure classification: the assessment of an additional predictive value of pulse pressure on mortality.
Thomas F; Blacher J; Benetos A; Safar ME; Pannier B
J Hypertens; 2008 Jun; 26(6):1072-7. PubMed ID: 18475143
[TBL] [Abstract][Full Text] [Related]
17. Evidence for benefits of perindopril in hypertension and its complications.
Laurent S
Am J Hypertens; 2005 Sep; 18(9 Pt 2):155S-162S. PubMed ID: 16125052
[TBL] [Abstract][Full Text] [Related]
18. From 'optimal' to 'borderline' blood pressure in subjects under chronic antihypertensive therapy.
Vergnaud AC; Protogerou AD; Blacher J; Safar ME
J Hypertens; 2008 Jan; 26(1):138-44. PubMed ID: 18090551
[TBL] [Abstract][Full Text] [Related]
19. Increased vascular compliance/decreased cardiovascular risk: what the studies tell us.
Frishman WH
Heart Dis; 2000; 2(5):384-8. PubMed ID: 11728287
[TBL] [Abstract][Full Text] [Related]
20. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity.
Dhakam Z; McEniery CM; Yasmin ; Cockcroft JR; Brown MJ; Wilkinson IB
Am J Hypertens; 2006 Feb; 19(2):214-9. PubMed ID: 16448896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
